Lupin gets USFDA tentative nod for anti-bacterial tablets

The company's US subsidiary, Gavis Pharmaceuticals, has received tentative approval for its moxifloxacin hydrochloride tablets

|Sep 06, 2016, 16:22:24 IST

New Delhi: Drug firm Lupin has received tentative approval from the US health regulator to market its generic anti-bacterial moxifloxacin hydrochloride tablets in the American market.[caption id="attachment_2359544" align="alignleft" width="380"] Reuters[/caption]The company's US subsidiary, Gavis Pharmaceuticals, has received tentative approval for its moxifloxacin hydrochloride tablets, 400 mg, from the United States Food and Drug Administration (USFDA), Lupin said in a filing to BSE.The approval is to market the company's product, a generic version of Bayer Healthcare Pharmaceuticals' Avelox tablets in the same strength, it added.Avelox had US sales of $30.1 million as per IMS MAT June 2016, Lupin said.The stock of Lupin today closed at Rs 1,535.50 on BSE, up 1.28 percent from its previous close.

NDTA asks Connaught Place shops, offices and restaurants to close by 6:30 pm today

NDTA says move follows advisory from NDMC Chairman and Vice Chairman amid prevailing security situation in Connaught Place

1 min read

EU slaps Google with $1 billion antitrust fine over Play Store and Search practices

European Commission says Google unfairly favoured its own services on Search and the Play Store, violating the Digital Markets Act; the company calls the decision harmful to businesses and consumers.

1 min read

Brent crude flirts with $100, reigniting inflation and forex concerns for India

Experts say a prolonged rally above $100 per barrel is unlikely, but sustained high oil prices could push up inflation, widen the current account deficit and pressure the rupee.

2 min read

Can a record May offset a shrunk international schedule and help IndiGo turn a profit?

Record domestic market share boosts operating performance, but forex losses, rising oil prices and geopolitical disruptions could weigh on IndiGo's bottom line.

3 min read

China has dominated Myanmar’s rare earth mines — now India eyes deal to harness country’s critical minerals

India is deepening rare earth cooperation with Myanmar as New Delhi seeks alternative sources of critical minerals dominated by China, including dysprosium and terbium used in EVs, defence systems and clean energy technologies

6 min read

Up Next